For the Inventor, By the Inventor

Enter inventor name

Ann Arbor, MI, United States of America

Kjell Johnson

This inventor holds 21 USPTO granted patents and 2 published patent applications, primarily in Quantitative Imaging. Top assignees: Elucid Bioimaging Inc., Elucid Bioiwaging Inc.. Active years: 2019-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kjell Johnson. Retrieved from https://idiyas.com/inventor/kjell-johnson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 2)

% Patents Active = 100.0

Average Co-Inventor Count = 5.9

ph-index = 14

Forward Citations = 689(Granted Patents)

Company Filing History:

Elucid Bioimaging Inc.

Elucid Bioiwaging Inc.

Years Active: 2019-2025

Loading Chart...

Areas of Expertise:

Quantitative Imaging

Cardiovascular Disease

Atherosclerotic Plaque

Non-Invasive Diagnostics

Myocardial Ischemia

CT Angiography

Vasculopathy

Patient Care

Imaging Biomarkers

Radiology

Stenosis

Cancer Subtype

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12236595 - Characterizing permeability, neovascularization, necrosis, collagen breakdown, or inflammation (2025-02-25),

2. 12229957 - Systems and methods for diagnostics for management of cardiovascular disease patients (2025-02-18),

3. 12159406 - Determining biological properties of atherosclerotic plaque, coronary artery disease, or vasculopathy (2024-12-03),

4. 12141975 - Myocardial ischemia prediction (2024-11-12),

5. 12136214 - Non-invasive imaging to inform patient care (2024-11-05),

6. 12131472 - Non-invasive imaging to determine health and disease (2024-10-29),

7. 12131471 - Longitudinal change measures for optimizing patient care (2024-10-29),

8. 12106477 - Segmenting permeability, neovascularization, necrosis, collagen breakdown, or inflammation to characterize atherosclerotic plaque, coronary artery disease, or vasculopathy (2024-10-01),

9. 12073561 - Multiscale modeling to determine molecular profiles from radiology (2024-08-27),

10. 12045983 - Functional measures of stenosis significance (2024-07-23),

11. 12039765 - Systems and methods for optimizing analysis of CT angiography (2024-07-16),

12. 11676359 - Non-invasive quantitative imaging biomarkers of atherosclerotic plaque biology (2023-06-13),

13. 11607179 - Non-invasive risk stratification for atherosclerosis (2023-03-21),

14. 11120312 - Quantitative imaging for cancer subtype (2021-09-14),

15. 11113812 - Quantitative imaging for detecting vulnerable plaque (2021-09-07),

Title: The Innovative Journey of Kjell Johnson

Introduction: Kjell Johnson, a pioneering inventor based in Ann Arbor, MI, has made significant contributions to the world of technology and innovation.

Latest Patents: Kjell Johnson's latest patents include groundbreaking inventions in the field of renewable energy and sustainable transportation.

Career Highlights: With a career spanning over two decades, Kjell Johnson has established himself as a leading figure in the tech industry, known for his innovative solutions and forward-thinking approach.

Collaborations: Throughout his career, Kjell Johnson has collaborated with top research institutions, universities, and leading tech companies to bring his inventions to life and make a lasting impact on society.

Conclusion: Kjell Johnson's passion for innovation and dedication to creating a better future through his inventions continue to inspire the next generation of inventors and entrepreneurs.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…